ST羅普(002333.SZ):上半年業績由盈轉虧 預虧1600萬元-2300萬元
格隆匯 7 月 14日丨ST羅普(002333.SZ)披露2020年半年度業績預告,預計歸屬於上市公司股東的淨虧損1600萬元-2300萬元,上年同期盈利5408萬元。公司2020年半年度淨利潤較去年同期變動的主要原因為:
1、報告期內,受疫情影響,第一季度產品銷售、營業收入較上年同期有較大幅下降。於二季度全面復工復產後,經營情況有較大改善,各主要財務指標同比及環比均有好轉。
2、報告期內,非經常性損益對公司淨利潤的影響較去年同期大幅減少,去年同期確認出售子公司股權的投資收益約9,173萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.